330 related articles for article (PubMed ID: 7582508)
1. The in vitro pharmacology of ZM 241385, a potent, non-xanthine A2a selective adenosine receptor antagonist.
Poucher SM; Keddie JR; Singh P; Stoggall SM; Caulkett PW; Jones G; Coll MG
Br J Pharmacol; 1995 Jul; 115(6):1096-102. PubMed ID: 7582508
[TBL] [Abstract][Full Text] [Related]
2. Activation of multiple sites by adenosine analogues in the rat isolated aorta.
Prentice DJ; Hourani SM
Br J Pharmacol; 1996 Jul; 118(6):1509-17. PubMed ID: 8832079
[TBL] [Abstract][Full Text] [Related]
3. A1 and A2 adenosine receptor modulation of contractility in the cauda epididymis of the guinea-pig.
Haynes JM; Alexander SP; Hill SJ
Br J Pharmacol; 1998 Oct; 125(3):570-6. PubMed ID: 9806342
[TBL] [Abstract][Full Text] [Related]
4. Activation of two sites by adenosine receptor agonists to cause relaxation in rat isolated mesenteric artery.
Prentice DJ; Payne SL; Hourani SM
Br J Pharmacol; 1997 Dec; 122(7):1509-15. PubMed ID: 9421303
[TBL] [Abstract][Full Text] [Related]
5. A1 adenosine receptor inhibition of cyclic AMP formation and radioligand binding in the guinea-pig cerebral cortex.
Alexander SP; Curtis AR; Kendall DA; Hill SJ
Br J Pharmacol; 1994 Dec; 113(4):1501-7. PubMed ID: 7889308
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of adenosine receptors mediating relaxation in hamster isolated aorta.
Prentice DJ; Hourani SM
Naunyn Schmiedebergs Arch Pharmacol; 2000 Nov; 362(4-5):427-34. PubMed ID: 11111838
[TBL] [Abstract][Full Text] [Related]
7. The non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A2a adenosine receptor antagonist.
Zocchi C; Ongini E; Conti A; Monopoli A; Negretti A; Baraldi PG; Dionisotti S
J Pharmacol Exp Ther; 1996 Feb; 276(2):398-404. PubMed ID: 8632302
[TBL] [Abstract][Full Text] [Related]
8. Binding of the radioligand [3H]-SCH 58261, a new non-xanthine A2A adenosine receptor antagonist, to rat striatal membranes.
Zocchi C; Ongini E; Ferrara S; Baraldi PG; Dionisotti S
Br J Pharmacol; 1996 Apr; 117(7):1381-6. PubMed ID: 8730729
[TBL] [Abstract][Full Text] [Related]
9. Species differences in brain adenosine A1 receptor pharmacology revealed by use of xanthine and pyrazolopyridine based antagonists.
Maemoto T; Finlayson K; Olverman HJ; Akahane A; Horton RW; Butcher SP
Br J Pharmacol; 1997 Nov; 122(6):1202-8. PubMed ID: 9401787
[TBL] [Abstract][Full Text] [Related]
10. Identification and functional characterization of A1 and A2 adenosine receptors in the rat vas deferens: a comparison with A1 receptors in guinea pig left atrium and A2 receptors in guinea pig aorta.
Martin PL; May JM
J Pharmacol Exp Ther; 1994 Jun; 269(3):1228-35. PubMed ID: 8014866
[TBL] [Abstract][Full Text] [Related]
11. Effects of adenosine receptor agonists on guinea-pig isolated working hearts and the role of endothelium and NO.
Maddock HL; Broadley KJ; Bril A; Khandoudi N
J Pharm Pharmacol; 2002 Jun; 54(6):859-67. PubMed ID: 12079003
[TBL] [Abstract][Full Text] [Related]
12. Adenosine receptor-mediated contraction and relaxation of guinea-pig isolated tracheal smooth muscle: effects of adenosine antagonists.
Farmer SG; Canning BJ; Wilkins DE
Br J Pharmacol; 1988 Oct; 95(2):371-8. PubMed ID: 3228669
[TBL] [Abstract][Full Text] [Related]
13. Adenosine analogues relax guinea-pig taenia caeci via an adenosine A2B receptor and a xanthine-resistant site.
Prentice DJ; Hourani SM
Eur J Pharmacol; 1997 Mar; 323(1):103-6. PubMed ID: 9105884
[TBL] [Abstract][Full Text] [Related]
14. Adenosine receptors mediate both contractile and relaxant effects of adenosine in main pulmonary artery of guinea pigs.
Szentmiklósi AJ; Ujfalusi A; Cseppentö A; Nosztray K; Kovács P; Szabó JZ
Naunyn Schmiedebergs Arch Pharmacol; 1995 Apr; 351(4):417-25. PubMed ID: 7543187
[TBL] [Abstract][Full Text] [Related]
15. 2-Phenylethoxy-9-methyladenine: an adenosine receptor antagonist that discriminates between A2 adenosine receptors in the aorta and the coronary vessels from the guinea pig.
Martin PL; Ueeda M; Olsson RA
J Pharmacol Exp Ther; 1993 Apr; 265(1):248-53. PubMed ID: 8474010
[TBL] [Abstract][Full Text] [Related]
16. Functional characterization of three adenosine receptor types.
Gurden MF; Coates J; Ellis F; Evans B; Foster M; Hornby E; Kennedy I; Martin DP; Strong P; Vardey CJ
Br J Pharmacol; 1993 Jul; 109(3):693-8. PubMed ID: 8358566
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the prejunctional adenosine receptors in the rat anococcygeus muscle.
Coates J; Green MA; Sheehan MJ; Strong P
J Pharm Pharmacol; 1994 Nov; 46(11):906-10. PubMed ID: 7897597
[TBL] [Abstract][Full Text] [Related]
18. Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]-SCH 58261.
Dionisotti S; Ongini E; Zocchi C; Kull B; Arslan G; Fredholm BB
Br J Pharmacol; 1997 Jun; 121(3):353-60. PubMed ID: 9179373
[TBL] [Abstract][Full Text] [Related]
19. A novel non-xanthine adenosine A1 receptor antagonist.
Terai T; Kita Y; Kusunoki T; Shimazaki T; Ando T; Horiai H; Akahane A; Shiokawa Y; Yoshida K
Eur J Pharmacol; 1995 Jun; 279(2-3):217-25. PubMed ID: 7556404
[TBL] [Abstract][Full Text] [Related]
20. Characterization of adenosine receptors mediating the vasodilator effects of adenosine receptor agonists in the microvasculature of the hamster cheek pouch in vivo.
Nicholls J; Hourani SM; Hall JM
Auton Autacoid Pharmacol; 2002 Aug; 22(4):209-14. PubMed ID: 12656946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
